共 50 条
- [1] High body mass index is not associated with increased treatment failure in infliximab treated pediatric patients with inflammatory bowel disease JGH OPEN, 2020, 4 (03): : 446 - 453
- [10] A Retrospective Analysis of the Impact of Body Mass Index on Treatment FaiLure of UsTekinumab Within an Inflammatory Bowel Disease Population (BELT-IBD) AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S1049 - S1050